Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
World Journal of Urology|March 21, 2018
Mirabegron is alternative to antimuscarinic agents for overactive bladder without higher risk in hypertension: a systematic review and meta-analysisHsiao-Ling Chen, Tun-Chieh Chen, Hsiu-Mei Chang, et al.
Prostate Cancer and Prostatic Diseases|August 30, 2020
Abiraterone and enzalutamide had different adverse effects on the cardiovascular system: a systematic review with pairwise and network meta-analysesHsiang Ying Lee, Hsiao-Ling Chen, Jeremy Yuen-Chun Teoh, et al.
Cancers|January 11, 2022
Salvage Therapy for Relapsed Malignant Pleural Mesothelioma: A Systematic Review and Network Meta-AnalysisYu-Chen Tsai, Hsiao-Ling Chen, Tai-Huang Lee, et al.
International Journal of Antimicrobial Agents|April 23, 2026
Multidrug-Resistant Acinetobacter baumannii Pneumonia in Clinical Therapy: A Systematic Review and Network Meta-analysis on Effectiveness and Safety of Different Antibiotic Combination RegimensShao-Yuan Hao, Hau-Yu Lin, Po-I Yeh, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
P2Y12 Inhibitor Monotherapy versus Conventional Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Meta-AnalysisWen-Han Feng, Yong-Chieh Chang, Yi-Hsiung Lin, et al.
Journal of Clinical Medicine|June 24, 2022
Impact of Smoking Status in Combination Treatment with EGFR Tyrosine Kinase Inhibitors and Anti-Angiogenic Agents in Advanced Non-Small Cell Lung Cancer Harboring Susceptible EGFR Mutations: Systematic Review and Meta-AnalysisTai-Huang Lee, Hsiao-Ling Chen, Hsiu-Mei Chang, et al.
Journal of Clinical Medicine|October 13, 2021
First-Line Anaplastic Lymphoma Kinase (ALK) Inhibitors for ALK-Positive Lung Cancer in Asian Populations: Systematic Review and Network Meta-AnalysisKuan-Li Wu, Hsiao-Ling Chen, Ying-Ming Tsai, et al.
Cancers|April 30, 2021
Systematic Review and Network Meta-Analysis of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Treatment-Naïve ALK-Positive Lung CancerCheng-Hao Chuang, Hsiao-Ling Chen, Hsiu-Mei Chang, et al.
Pageof 2